US EditionGalaxy Brain Scientific's Technology Enables Landmark Parkinson's Study Published in Nature, Redefining Disease Mechanism
International study of over 800 participants identifies somato-cognitive action network as key to Parkinson’s, linking motor and non-motor symptoms for targeted treatments.
- An international team, including Washington University in St. Louis, Tsinghua University, Peking University, and Harvard University, published in Nature on Feb. 5, 2026, revealing core Parkinson’s mechanisms.
- For decades the field treated PD as a basal ganglia disorder, but with over 13 million people worldwide affected, existing medication and DBS limits demand new approaches.
- Analysis showed a circuit signature involving the SCAN network using data from over 800 participants and precision functional neuroimaging, with all methods detailed in the study.
- Galaxy Brain Scientific Inc. has begun a pivotal registration trial for the technology, and Nico U. Dosenbach, MD, PhD, said targeting the network could slow or reverse disease progression.
- The mechanism offers a unifying perspective with implications across disorders, as the study shows all effective PD therapies reduce abnormal SCAN–deep brain connectivity and plans to apply the approach to Autism and Alzheimer's.
43 Articles
43 Articles
Scientists have identified a crucial brain network that is affected by Parkinson's disease. The results change doctors' understanding of what causes the symptoms of the disease and can open the way to treatment...
Parkinson's disease could be better understood through an international study. Researchers have identified the SCAN network, a larger than imagined brain area, responsible for symptoms.
LoudounTimes.com
Galaxy Brain Scientific's Technology Enables Landmark Parkinson's Study Published in Nature, Redefining Disease Mechanism
BEIJING, Feb. 5, 2026 /PRNewswire/ -- A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature that pinpoints the core functional circuit underlying Parkinson's disease (PD).…
Galaxy Brain Scientific’s Technology Enables Landmark Parkinson’s Study Published in Nature, Redefining Disease Mechanism
BEIJING, Feb. 5, 2026 /PRNewswire/ — A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published a study in Nature that pinpoints the core functional circuit underlying Parkinson’s disease (PD). The findings redefine the biological mechanism of PD and provide a scientific basis for developing precision neural circuit stimulation strategies for treating the condition. PD currently…
Coverage Details
Bias Distribution
- 54% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
